|Articles|January 15, 2020
Case study to demonstrate sensitivity in Immunogenicity Assay should be based on result of both screening and Confirmatory tier
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
4
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
5